Viewing Study NCT02614495


Ignite Creation Date: 2025-12-24 @ 2:13 PM
Ignite Modification Date: 2026-03-03 @ 2:21 AM
Study NCT ID: NCT02614495
Status: COMPLETED
Last Update Posted: 2020-02-13
First Post: 2015-11-24
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Sulfatinib in Treating Advanced Medullary Thyroid Carcinoma and Iodine-refractory Differentiated Thyroid Carcinoma
Sponsor: Hutchison Medipharma Limited
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module